US EditionSynerFuse™ & Velentium Medical Partnering to Scale Integrated Spinal Fusion & Direct Nerve Stimulation Procedure
- SynerFuse and Velentium Medical announced plans to scale their patented SynerFuse e-TLIF procedure implant device following the completion of their proof-of-concept study.
- Spinal fusion procedures can lead to complications like Failed Back Surgery Syndrome, which affects many patients and costs the U.S. Healthcare system $20 billion per year.
- The SynerFuse e-TLIF procedure aims to improve patient safety with a single incision and integrates neuromodulation with traditional spinal fusion techniques.
- Doctors believe this new therapy offers a safe option for treating back and leg pain while reducing opioid exposure for patients.
Insights by Ground AI
Does this summary seem wrong?
14 Articles
14 Articles
All
Left
Center
4
Right
Coverage Details
Total News Sources14
Leaning Left0Leaning Right0Center4Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage